Labcorp posts 2025 Q3 results press release

Labcorp Holdings Inc. filed a current report to furnish a press release announcing its 2025 third quarter results.

Rhea-AI Filing Summary

Labcorp Holdings Inc. filed a current report to furnish a press release announcing its 2025 third quarter results. The filing identifies a press release dated October 28, 2025, titled “Labcorp Announces 2025 Third Quarter Results” as an exhibit, indicating the company has publicly shared its Q3 2025 performance details through that document.

The company lists its common stock, par value $0.10 per share, as trading on the New York Stock Exchange under the symbol LH. The report is signed on behalf of Labcorp by Executive Vice President and Chief Legal Officer Sandra D. van der Vaart.

8-K Event Classification

2 items: 2.02, 9.01

2 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What event does Labcorp Holdings Inc. (LH) report in this 8-K?

Labcorp reports that it has issued a press release titled “Labcorp Announces 2025 Third Quarter Results”, which is furnished as Exhibit 99.1.

Where can investors find Labcorp (LH) 2025 third quarter results?

Investors can refer to Exhibit 99.1 of this report, which is the press release titled “Labcorp Announces 2025 Third Quarter Results.”

What exhibits are included in this Labcorp (LH) Form 8-K?

The report includes Exhibit 99.1, a Q3 2025 results press release, and Exhibit 104, the cover page interactive data file embedded in the Inline XBRL document.

Who signed this Labcorp Holdings Inc. (LH) Form 8-K?

The report is signed on behalf of Labcorp by Sandra D. van der Vaart, Executive Vice President, Chief Legal Officer and Corporate Secretary.

On which exchange is Labcorp (LH) common stock listed?

Labcorp’s common stock, $0.10 par value, is listed on the New York Stock Exchange under the trading symbol LH.

Does this Labcorp (LH) filing itself contain detailed Q3 2025 financial figures?

The report indicates that detailed Q3 2025 results are provided in Exhibit 99.1, the accompanying press release, rather than in the body of the report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/28/2025 - 06:55 AM EDT Learn about SEC filing dates

0000920148false00009201482025-10-282025-10-28

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.  20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

October 28, 2025

(Date of earliest event reported)

LABCORP HOLDINGS INC.

(Exact Name of Registrant as Specified in its Charter)

Delaware

1-11353

99-2588107

(State or other jurisdiction of Incorporation)

(Commission File Number)

(I.R.S. Employer Identification No.)

358 South Main Street

Burlington

,

North Carolina

27215

(Address of principal executive offices)

(Zip Code)

(Registrant’s telephone number including area code) 336-229-1127

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each class

Trading Symbol

Name of exchange on which registered

Common Stock, $0.10 par value

LH

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).             

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition

Item 9.01			Financial Statements and Exhibits.
Exhibit			Exhibit Name
Exhibit 99.1			Press Release dated October 28, 2025 issued by Labcorp titled “Labcorp Announces 2025 Third Quarter Results”
Exhibit 104			Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LABCORP HOLDINGS INC.

Registrant

Date: October 28, 2025			By:			/s/ SANDRA D. VAN DER VAART
						Sandra D. van der Vaart
						Executive Vice President, Chief Legal Officer and Corporate Secretary